Table 1.
Effects of PCDD/Fs, DL-PCBs, and curcumin on BW, liver weight, and HSI of rats (± s, g).
| Group | Sex | Initial BW | Mid-study BW | Final BW | Final empty stomach weight | Final liver weight | HSI (%) |
|---|---|---|---|---|---|---|---|
| A (n = 4) | Female | 70.3 ± 2.6 | 158.0 ± 3.5 | 206.4 ± 3.4 | 183.6 ± 4.0 | 6.6 ± 0.4 | 3.6 ± 0.1 |
| B (n = 4) | 72.5 ± 3.2 | 158.2 ± 7.0 | 206.0 ± 13.1 | 183.1 ± 10.3 | 6.8 ± 0.3 | 3.7 ± 0.2 | |
| C (n = 8) | 70.6 ± 1.7 | 154.5 ± 5.3 | 197.4 ± 7.7 | 181.3 ± 4.2 | 6.4 ± 0.6 | 3.6 ± 0.3 | |
| A (n = 4) | Male | 72.4 ± 1.2 | 179.2 ± 13.6 | 288.0 ± 17.7 | 249.8 ± 17.7 | 8.8 ± 0.6 | 3.5 ± 0.1 |
| B (n = 4) | 72.8 ± 1.8 | 182.0 ± 4.0 | 288.2 ± 19.6 | 252.0 ± 15.8 | 9.8 ± 1.0 | 3.9 ± 0.2# | |
| C (n = 8) | 71.8 ± 3.8 | 178.0 ± 10.8 | 283.8 ± 16.7 | 248.4 ± 17.0 | 9.0 ± 0.7 | 3.6 ± 0.1* |
The results are expressed as the mean ± standard deviation. Group A: control; Group B: dioxins + DL-PCBs; Group C: curcumin intervention; #p < 0.05 vs. group A (Q test); *p < 0.05 vs. group B (Q test).